ストックスクリーナーアプリを入手
24.17
0.33%
-0.08
Pfizer Inc (PFE) 最新ニュース
Is Pfizer on Track to Launch Its Next Lipitor -- This Time in the Weight-Loss Market? - AOL.com
Pfizer (PFE) Gets An Opening In ATTR CM After AstraZeneca Trial Failure - Yahoo Finance
Merck, Pfizer, Astellas Bladder Cancer Treatment Approved by FDA - Moomoo
Pfizer, Astellas Expand PADCEV-Keytruda Label With FDA Nod In Bladder Cancer - Benzinga
FDA Approves Expanded Use of Pfizer's Padcev (PFE) with Merck's Keytruda - GuruFocus
Pfizer Poised for Mixed Second Quarter, RBC Says - marketscreener.com
Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance Singapore
Nathan Berman communicating with investors over Pfizer project - The Real Deal
Pfizer wins FDA label expansion for Padcev plus Merck’s Keytruda in bladder cancer - Seeking Alpha
BofA Securities Adjusts Pfizer Price Target to $26 From $27 - marketscreener.com
Pfizer Vaccine Dispute Hits Polish, Romania Air Traffic Agencies - ThePrint
McDonald’s or Pfizer: One Offers Real Growth, One Just Pays You to Wait - AOL.com
PFIZER INC : RBC reiterates its Neutral rating - marketscreener.com
Pfizer Seen Reporting Q2 Revenue In Line With Consensus, EPS Below Estimates, RBC Says - marketscreener.com
Polish air traffic control faces funding freeze over COVID vaccine ruling - marketscreener.com
Jim Cramer on Pfizer: “I Can’t Come Up With Where the Growth Is” - Yahoo Finance
This Week’s Leadership Moves: Pfizer, Commonwealth Bank, and GE HealthCare - CDO Magazine
Stability concerns linger at former Pfizer building - PIX11
Stability concerns linger for former Pfizer building - PIX11
Pfizer's Depo-Provera Settlement: What Women With Meningioma Need to Know About the June 2026 Agreement - JD Supra
Pfizer Stock Leads 3 AI Healthcare Picks Worth A Closer Look - simplywall.st
Pfizer Trades at Just 8.5x Earnings While Peers Fetch 16x. Is the Discount Justified? - TIKR.com
Pfizer building inspector, subcontractor’s violations face scrutiny as probes proceed - The Real Deal
Pfizer Fails to Revive $108 Million Cancer-Drug Patent Verdict - Bloomberg Law News
NYC workers continue stabilizing 29 floors of former Pfizer HQ in Midtown. Here's the latest on the investigation. - CBS News
Did FDA’s IBRANCE Maintenance Approval Just Shift Pfizer’s (PFE) Oncology-Focused Investment Narrative? - Yahoo Finance
AstraZeneca wins appeal in Pfizer patent dispute over Tagrisso By Investing.com - Investing.com Canada
Efforts continue to shore up former Pfizer headquarters after concerns of collapse - CBS News
Pfizer Refines Early-Stage Drug Formulations With New Phase 1 Bioavailability Study - TipRanks
BridgeBio hits 52-week high on late-stage trial setback for Astra/ Ionis (update) - Seeking Alpha
‘It Kills Me to Say That’: Cramer Won’t Recommend Pfizer, Even With Its 7% Dividend - Yahoo Finance
BenchSci Names Former Pfizer R&D Chief Dr. Mikael Dolsten as Chairman of the Board - Yahoo Finance Singapore
Pfizer Inc. outlines pipeline priorities as a major U.S. drugmaker - Ad-hoc-news.de
PFE Stock Quote Price and Forecast - CNN
MetroLoft says it has ‘identified the issue’ with the old Pfizer building - PIX11
NCLA to Fifth Circuit: Revive Suit Against Gov’t-Led Censorship of Covid Vaccine-Injured Americans - GlobeNewswire Inc.
Mamdani believes Pfizer building issue was a ‘breakdown’ - pix11.com
Pfizer (PFE) On IBRANCE Approval And Dividend Move Has Valuation Back In Focus - simplywall.st
Pfizer Building Developer Says Buckled Columns Were 'Freak Accident' Caused by Weight of New Addition - Realtor.com
Enterprise value to EBIT forward of Pfizer Inc Shs Cert Deposito Arg Repr 0.25 Shs – BCBA:PFE.B - TradingView
Engineering Failure Likely Behind Pfizer Project Scare - The Real Deal
Former Pfizer headquarters now "safe and stable" after steel columns buckled - CBS News
Stabilization efforts continue at old Pfizer building - PIX11
Did the old NYC Pfizer building collapse? Not quite - PIX11
After collapse scare, Pfizer building stabilization efforts continue - The Real Deal
Is Pfizer (PFE) Undervalued After IBRANCE Won A New FDA Approval? - Yahoo Finance
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Then vs. Now: Molecular Design - Pfizer
JPMorgan Adjusts Price Target on Pfizer to $28 From $30 - marketscreener.com
How Pfizer’s (PFE) Dividend Record Separates Tax Treatment From Business Momentum - Yahoo Finance
Pfizer Prevnar 20 by Pfizer Inc.adult pneumonia protection pushes vaccine portfolio - AD HOC NEWS
Manhattan Building Remains Unstable; Officials Warn of Collapse - TODAY.com
BioNTech and Pfizer score win in UPC dispute over COVID-19 vaccines against Promosome - JUVE Patent
PFIZER INC : JP Morgan remains Neutral - marketscreener.com
Stabilization work underway at old Pfizer building in Manhattan - Yahoo
Former Pfizer HQ deemed stable by NYC Department of Buildings after collapse scare on Manhattan's East Side - ABC7 New York
Pfizer stock holds on to its business case. Focus shifts to the pipeline. - AD HOC NEWS
Column Failure at Pfizer Conversion Exposes Execution Risk in Adaptive Reuse - Propmodo
“Freak accident”: Pfizer building developer denies risk of collapse - The Real Deal
What to Know About the Building at Risk of Collapse in Manhattan - The New York Times
Unstable Ex-Pfizer Office Spurs Evacuations In Manhattan - Law360
Graft vs Host Disease Pipeline 2026: In-depth Clinical Trials Analysis and Emerging Therapies Report by DelveInsight | Cellestia Biotech, Pfizer, Chia Tai Tianqing Pharma, Regimmune Corp - Barchart.com
Street closures, transit changes after old Pfizer building caves in - PIX11
Daycare owner near buckled Pfizer building speaks with PIX11 News - PIX11
Union lashes out against Midtown building developers: ‘Could have been hurt or killed’ - PIX11
2 Healthcare Stocks to Buy for Their Dividends—and Why Pfizer Isn’t One of Them - Barron's
Former Pfizer Building Is Crumbling—Just as the Stock Has - Barron's
Pfizer building in Midtown beginning to stabilize: Mamdani - PIX11
Buckling ex-Pfizer HQ hit with multiple DOB violations last year - The Real Deal
Construction workers evacuate old Pfizer building over concerns of potential collapse, amid renovation by Gensler - The Architect’s Newspaper
Pfizer building has concerning history of violations, records show - PIX11
3.72%
1.23%
大文字化:
|
ボリューム (24 時間):